Showing results (51-60 of 137) with videos related to
Sort By:
Pageof 14
Future Oncology (London, England)|June 6, 2017
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumorsSara Pusceddu, Natalie Prinzi, Giuseppe Lo Russo, et al.Current Drug Targets|May 4, 2016
Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old ProblemGiuseppe Lo Russo, Marianna Macerelli, Marco Platania, et al.Journal of Ovarian Research|May 16, 2014
Fertility drugs, reproductive strategies and ovarian cancer riskFederica Tomao, Giuseppe Lo Russo, Gian Paolo Spinelli, et al.Clinical Lung Cancer|August 8, 2025
Rationale and Design of the AUSTRAL trial: An Open-Label, Multicenter, Phase II Study Evaluating Radiotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Stage III NSCLC Patients With Thoracic Relapses and/or Oligometastases After the PACIFIC RegimenAndrea Riccardo Filippi, Eliana Rulli, Diego Signorelli, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2016
Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumorsGiuseppe Lo Russo, Sara Pusceddu, Natalie Prinzi, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 5, 2016
Treatment of lung large cell neuroendocrine carcinomaGiuseppe Lo Russo, Sara Pusceddu, Claudia Proto, et al.Critical Reviews in Oncology/Hematology|March 16, 2021
Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cakeAlessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective StudyMattia Boeri, Massimo Milione, Claudia Proto, et al.Journal of Medical Case Reports|June 22, 2013
A 68-year-old Caucasian man presenting with urinary bladder lymphoepithelioma: a case reportGian Paolo Spinelli, Giuseppe Lo Russo, Alberto Pacchiarotti, et al.Cancers|December 29, 2019
Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer PatientsFederico Nichetti, Francesca Ligorio, Emma Zattarin, et al.Pageof 14